During the nine months of pregnancy, the woman’s organism undergoes several significant changes. Among them may be the appearance of gestational diabetes, a condition characterized by high blood sugar levels.
According to Renato de Oliveira, an infertile and gynecologist from Cryogenesis, during pregnancy, hormones can prevent insulin from properly fulfilling its function and, when this happens, glucose levels can increase in the blood. “Gestational diabetes usually begins in the middle of pregnancy and most often disappears after delivery. It is worth noting that even a woman who has never had diabetes can have the problem in pregnancy”.
The specialist also points out that increased thirst, frequent urination and blurred vision are some of the rare discomforts that appear, as the disease rarely ends up causing symptoms. Therefore, frequent examinations are necessary. “It is extremely important that all pregnant women take an oral glucose tolerance test between the 24th and 28th week of pregnancy to check their blood glucose levels, as long as their blood glucose levels are normal at the beginning of pregnancy. If it is high, diabetes can already be considered.
Treatment – if the disease is diagnosed during pregnancy the doctor should follow the pregnancy so that complications such as miscarriage, pre-eclampsia, risk of urinary or respiratory infection and the need for a caesarean section due to the size of the baby, which can be very large, can be avoided. In addition, some care should be taken with food and physical activity. If blood glucose control is difficult, insulin may be used.
Cryogenesis, which was born in São Paulo and has more than 16 years of experience with stem cells, is an institutional member of AABB (North American Association of Blood Banks). The clinic is a reference in stem cell collection and cryopreservation services, reproductive medicine, platelet gel and apheresis, including the differentiated technique of extracorporeal photopheresis. Its mission is to stimulate the development of biotechnology through research, ensuring a cellular reserve for future genetic treatment.